日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

US Food and Drug Administration Approval of Biologic Drugs for Use in Children and Adolescents

美国食品药品监督管理局批准生物制剂用于儿童和青少年

Lyu, Ning; Schneeweiss, Sebastian; Bourgeois, Florence T; Savage, Timothy J

Subtypes and corneal astigmatism in pediatric persistent fetal vasculature

儿童持续性胎儿血管畸形的亚型和角膜散光

Zhang, Shao-Hua; Lyu, Ning; Hong, Ying-Ying; Lu, Yi; Ji, Ying-Hong

Coupled Au Nanoparticle-Cavity Nanostructures for Precise Control in Resonance-Driven Photocatalytic Reactions

用于精确控制共振驱动光催化反应的耦合金纳米粒子-腔纳米结构

Lyu, Ning; Edirisooriya, Anjalie; Fusco, Zelio; Zhao, Shenyou; Beck, Fiona J; David, Christin

Matching-Adjusted Indirect Comparison of Arterial FOLFOX and Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌动脉FOLFOX方案与阿特珠单抗-贝伐珠单抗方案的匹配调整间接比较

Zhang, Yi-Min; Wu, Xin-Tong; Yi, Jun-Zhe; Xu, Jie; Zhang, Yu-Nan; Lyu, Ning; Zhao, Ming

Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis

免疫疗法治疗肝细胞癌患者的合并用药与临床结局:一项多中心分析

Yi, Jun-Zhe; Xu, Jie; Zeng, Jiang-Zheng; Song, Yu-Jia; Zhang, Yu-Nan; Huang, Cheng-Mou; Li, Lei; Ding, Ke; Zhu, Zhi-Jian; Yuan, Dao-Zu; Fan, Yu-Wen; Ning, Shang-Fu; Liu, Xin; Zhang, Jian-Zhong; You, Yong-Fei; Zhou, Qi; Song, Hao-Jie; Tan, Gen-Jun; Wu, Xin-Tong; Guo, Rong-Ping; Chen, Min-Shan; Lyu, Ning; Zhao, Ming

Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study

在中国,介入动脉化疗与索拉非尼治疗晚期肝细胞癌的疗效比较:一项开放标签、随机、3期研究的卫生经济学评价

Chen, Qi-Feng; Jiang, Xiongying; Hu, Yue; Chen, Song; Lyu, Ning; Zhao, Ming

Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis

动脉FOLFOX化疗联合抗PD-(L)1免疫疗法一线治疗不可切除肝内胆管癌的疗效和安全性:倾向评分匹配分析

Hu, Yue; Jiang, Xiong-Ying; Cai, Xi; Chen, Song; Chen, Qi-Feng; Yi, Jun-Zhe; Zhong, Sui-Xing; Wang, Jiong-Liang; Xu, Jie; Tan, Gen-Jun; Lyu, Ning; Zhao, Ming

A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014-2023

2014-2023年肝细胞癌转化疗法的计量信息学研究

Chen, Qi-Feng; Jiang, Xiong-Ying; Chen, Min-Shan; Lyu, Ning; Zhao, Ming

Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate

提高肝细胞癌转化成功率:重点关注高客观缓解率的联合治疗

Chen, Qi-Feng; Chen, Song; Chen, Minshan; Lyu, Ning; Zhao, Ming

CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression

CircMYBL2通过调控E2F1表达促进肝细胞癌的进展。

Yi, Junzhe; Li, Binbin; Yin, Xiaomin; Liu, Lingrui; Song, Cailu; Zhao, Ying; Cai, Manbo; Tang, Hailin; Chen, Dong; Lyu, Ning